ASL is a translational research company with the primary objective of developing chemical sensing technology that permits real-time monitoring and control of critical chemical species within a targeted process. ASL’s unique approach includes the exclusive use of ASL’s Constrained Variance™ concept combined with the use of innovative optoelectronic devices designed in-house specifically for such analytical measurements. The resulting spectroscopic sensing technology represents an analytical platform with tremendous potential for monitoring and controlling key chemical intermediates of value in the biopharmaceutical, biomedical, clinical, and biotechnology settings.